Expression Quantitative Trait Locus Analysis in Systemic Sclerosis Identifies New Candidate Genes Associated With Multiple Aspects of Disease Pathology

To identify the genetic variants that affect gene expression (expression quantitative trait loci [eQTLs]) in systemic sclerosis (SSc) and to investigate their role in the pathogenesis of the disease.

[1]  S. Assassi,et al.  Type I interferon dysregulation in Systemic Sclerosis. , 2020, Cytokine.

[2]  Javier Martín,et al.  Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients , 2020, Annals of the Rheumatic Diseases.

[3]  Simon C. Potter,et al.  Complement genes contribute sex-biased vulnerability in diverse illnesses , 2020, Nature.

[4]  Javier Martín,et al.  Genomic opportunities for drug repositioning in systemic seropositive rheumatic diseases , 2020, Expert review of clinical immunology.

[5]  Ami A. Shah,et al.  HLA and autoantibodies define scleroderma subtypes and risk in African and European Americans and suggest a role for molecular mimicry , 2019, Proceedings of the National Academy of Sciences.

[6]  B. Hinz,et al.  Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases , 2019, Nature Reviews Rheumatology.

[7]  Ami A. Shah,et al.  Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile , 2019, Annals of the rheumatic diseases.

[8]  Howard Y. Chang,et al.  GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways , 2019, Nature Communications.

[9]  Javier Martín,et al.  Towards a Better Classification and Novel Therapies Based on the Genetics of Systemic Sclerosis , 2019, Current Rheumatology Reports.

[10]  J. Varga,et al.  Emerging targets of disease-modifying therapy for systemic sclerosis , 2019, Nature Reviews Rheumatology.

[11]  Gautier Koscielny,et al.  Open Targets Platform: new developments and updates two years on , 2018, Nucleic Acids Res..

[12]  M. Mayes,et al.  Associations of Multiple NOTCH4 Exonic Variants with Systemic Sclerosis , 2018, The Journal of Rheumatology.

[13]  J. Greenbaum,et al.  Impact of Genetic Polymorphisms on Human Immune Cell Gene Expression , 2018, Cell.

[14]  Jesper Tegnér,et al.  Impact of genetic risk loci for multiple sclerosis on expression of proximal genes in patients , 2018, Human molecular genetics.

[15]  C. Denton,et al.  Review: Defining a Unified Vascular Phenotype in Systemic Sclerosis , 2018, Arthritis & rheumatology.

[16]  A. García-Sáez,et al.  Bax, Bak and beyond — mitochondrial performance in apoptosis , 2018, The FEBS journal.

[17]  A. Barton,et al.  CD4+ and B lymphocyte expression quantitative traits at rheumatoid arthritis risk loci in untreated early arthritis: implications for causal gene identification , 2018 .

[18]  A. Letai,et al.  Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis , 2017, Science Translational Medicine.

[19]  Jeremy R. B. Newman,et al.  Disease-specific biases in alternative splicing and tissue-specific dysregulation revealed by multitissue profiling of lymphocyte gene expression in type 1 diabetes , 2017, Genome research.

[20]  T. Vyse,et al.  Profiling RNA-Seq at multiple resolutions markedly increases the number of causal eQTLs in autoimmune disease , 2017, bioRxiv.

[21]  C. Wijmenga,et al.  Context-specific effects of genetic variants associated with autoimmune disease , 2017, Human molecular genetics.

[22]  R. Salter,et al.  Dnase1L3 Regulates Inflammasome-Dependent Cytokine Secretion , 2017, Front. Immunol..

[23]  J. Belmont,et al.  The 2017 international classification of the Ehlers–Danlos syndromes , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[24]  E. Dermitzakis,et al.  Mapping eQTLs with RNA-seq reveals novel susceptibility genes, non-coding RNAs and alternative-splicing events in systemic lupus erythematosus , 2017, Human molecular genetics.

[25]  A. Hofman,et al.  Identification of context-dependent expression quantitative trait loci in whole blood , 2016, Nature Genetics.

[26]  Ge Tan,et al.  TFBSTools: an R/bioconductor package for transcription factor binding site analysis , 2016, Bioinform..

[27]  Javier Martín,et al.  Immunogenetics of systemic sclerosis: Defining heritability, functional variants and shared-autoimmunity pathways. , 2015, Journal of autoimmunity.

[28]  Jeffrey T. Chang,et al.  Dissecting the Heterogeneity of Skin Gene Expression Patterns in Systemic Sclerosis , 2015, Arthritis & rheumatology.

[29]  Viktor Martyanov,et al.  Systems Level Analysis of Systemic Sclerosis Shows a Network of Immune and Profibrotic Pathways Connected with Genetic Polymorphisms , 2015, PLoS Comput. Biol..

[30]  Jane Worthington,et al.  Identification of IL12RB1 as a Novel Systemic Sclerosis Susceptibility Locus , 2014, Arthritis & rheumatology.

[31]  Annette Lee,et al.  Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis. , 2014, American journal of human genetics.

[32]  Oliver Distler,et al.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative. , 2013, Arthritis and rheumatism.

[33]  Tariq Ahmad,et al.  Human SNP Links Differential Outcomes in Inflammatory and Infectious Disease to a FOXO3-Regulated Pathway , 2013, Cell.

[34]  M. Peters,et al.  Systematic identification of trans eQTLs as putative drivers of known disease associations , 2013, Nature Genetics.

[35]  Pedro G. Ferreira,et al.  Transcriptome and genome sequencing uncovers functional variation in humans , 2013, Nature.

[36]  M. Mayes,et al.  Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers , 2012, Current opinion in rheumatology.

[37]  A. Sonnenberg,et al.  Tetraspanin CD151 maintains vascular stability by balancing the forces of cell adhesion and cytoskeletal tension. , 2011, Blood.

[38]  Annette Lee,et al.  Identification of Novel Genetic Markers Associated with Clinical Phenotypes of Systemic Sclerosis through a Genome-Wide Association Strategy , 2011, PLoS genetics.

[39]  Andrey A. Shabalin,et al.  Matrix eQTL: ultra fast eQTL analysis via large matrix operations , 2011, Bioinform..

[40]  James Lyons-Weiler,et al.  Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension. , 2011, Arthritis and rheumatism.

[41]  Min Chen,et al.  The complement system in systemic autoimmune disease. , 2010, Journal of autoimmunity.

[42]  Annette Lee,et al.  Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus , 2010, Nature Genetics.

[43]  S. Shete,et al.  Association of the C8orf13-BLK region with systemic sclerosis in North-American and European populations. , 2010, Journal of autoimmunity.

[44]  G. Gilkeson,et al.  ETS transcription factors and regulation of immunity , 2006, Archivum Immunologiae et Therapiae Experimentalis.

[45]  R. Grahame,et al.  Joint hypermobility syndromes: the pathophysiologic role of tenascin-X gene defects. , 2004, Arthritis and rheumatism.

[46]  P. Love,et al.  TCR ζ chain in T cell development and selection , 1997 .

[47]  P. Grant,et al.  IgM receptor‐mediated transactivation of the IgH 3′ enhancer couples a novel Elf‐1‐AP‐1 protein complex to the developmental control of enhancer function. , 1995, The EMBO journal.

[48]  C. Y. Wang,et al.  Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. , 1993, Science.

[49]  N Rowell,et al.  Systemic sclerosis. , 1968, British medical journal.

[50]  Ash A. Alizadeh,et al.  SUPPLEMENTARY NOTE , 1879, Botanical Gazette.

[51]  L. Catrysse,et al.  A20 in inflammation and autoimmunity. , 2014, Trends in immunology.

[52]  S. Bhattacharyya,et al.  Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities , 2012, Nature Reviews Rheumatology.

[53]  Ami A. Shah,et al.  Fine mapping and conditional analysis identify a new mutation in the autoimmunity susceptibility gene BLK that leads to reduced half-life of the BLK protein , 2012, Annals of the rheumatic diseases.